BACE1-IN-12

Modify Date: 2024-01-10 15:27:13

BACE1-IN-12 Structure
BACE1-IN-12 structure
Common Name BACE1-IN-12
CAS Number 2479315-19-8 Molecular Weight 547.48
Density N/A Boiling Point N/A
Molecular Formula C29H28Cl2N6O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of BACE1-IN-12


BACE1-IN-12 (compound 7g) is a potent and BBB-penetrated BACE1 inhibitor, with an IC50 of 8.9 µM. BACE1-IN-12 shows selective BuChE (butyrylcholinesterase) inhibitory activity with an IC50 of 3.2 µM. BACE1-IN-12 shows effective antioxidant effect with an IC50 of 10.2 μM (DPPH). BACE1-IN-12 might be served as a potential anti-Alzheimer agent[1].

 Names

Name BACE1-IN-12

 BACE1-IN-12 Biological Activity

Description BACE1-IN-12 (compound 7g) is a potent and BBB-penetrated BACE1 inhibitor, with an IC50 of 8.9 µM. BACE1-IN-12 shows selective BuChE (butyrylcholinesterase) inhibitory activity with an IC50 of 3.2 µM. BACE1-IN-12 shows effective antioxidant effect with an IC50 of 10.2 μM (DPPH). BACE1-IN-12 might be served as a potential anti-Alzheimer agent[1].
Related Catalog
Target

IC50: 8.9 ± 0.20 µM (BACE1), 3.2 ± 0.2 µM (BuChE)[1]

References

[1]. Haghighijoo Z, et al. N-Cyclohexylimidazo[1,2-a]pyridine derivatives as multi-target-directed ligands for treatment of Alzheimer's disease. Bioorg Chem. 2020 Oct;103:104146.

 Chemical & Physical Properties

Molecular Formula C29H28Cl2N6O
Molecular Weight 547.48
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.